Xiaoming Xu
United States Food and Drug Administration
ORCID: 0000-0003-1672-0830Also affiliated with Center for Drug Evaluation and Research, Wenzhou Medical University, AbbVie (United States), Food and Drug Administration
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: “Reverse engineering of Onivyde® – Irinotecan liposome injection”.
Vivian Juang, Kaikai Wang, Ziyun Xia, Rose Ackermann, Minzhi Yu +10 more
Jason A. Griggs, Amol V. Janorkar, Xiaoming Xu, Ravi Chandran, Hao Mei +5 more
Ramesh Raghavachari, Douglas C. Kirkpatrick, David A. Keire, Xiaoming Xu, Patrick J. Faustino +1 more
Michael S. Bingham, Jingyi Dai, Young Kuk Jhon, Yan Wang, Bin Qin +5 more
Rokon Uz Zaman, Christine L Plavchak, William C. Smith, Hossein Birjandi Nejad, André O’Reilly Beringhs +3 more
W. Paul Segars, Xiaoming Xu, David A. Lynch, H. Page McAdams, Ehsan Samei +2 more